B

Ruxandra F Sîrbulescu1,2, Katharine Nicholson3,2, Kento Kawai1

  • 1Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

概括

哈普洛同一性B细胞疗法在肌缩性侧面硬化症 (ALS) 中表现有前途. 在小鼠模型和人类患者的输液证明了安全性,延迟了疾病的进展,并改善了生存率,这表明ALS的潜在新治疗途径.